Effect of Denosumab on Cellular Biomarkers in the Human Breast

NCT02099461 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer, Female, Breast

Interventions

DRUG: Denosumab
PROCEDURE: Percutaneous core needle breast biopsy

Sponsor

Amgen